greeksoup/ stock research
Stock research / United States / Funds / Syncona Portfolio Ltd

Syncona Portfolio Ltd

CIK 1725042 · latest 13F filed 7 August 2026 · Read the filing on EDGAR

Syncona Portfolio Ltd reported 1 US-listed holding worth $26.63 billion in its 13F for the quarter ended 30 June 2026, filed 7 August 2026. Its largest: Autolus Therapeutics PLC (100.0%). Against the quarter before, it opened 0 positions, added to 0, trimmed 0 and sold out of 1.

Reported holdings$26.63B+103476.8% on Q1 2026
Positions1-1 on Q1 2026
The largest ten100.0%of its reported holdings
Latest 13FQ2 2026filed 7 August 2026
Reported holdings, quarter by quarter
Q3 2024: $80.7 million in 3 positions$80.7MQ3 24Q4 2024: $53.0 million in 3 positions$53.0MQ4 24Q1 2025: $26.37 billion in 2 positions$26.4BQ1 25Q2 2025: $38.6 million in 2 positions$38.6MQ2 25Q3 2025: $27.73 billion in 2 positions$27.7BQ3 25Q4 2025: $34.32 billion in 2 positions$34.3BQ4 25Q1 2026: $25.7 million in 2 positions$25.7MQ1 26Q2 2026: $26.63 billion in 1 positions$26.6BQ2 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What it did on the quarter

Held 1Sold out 1
Held: 1Sold out: 1

Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held

Sold out of 1

  1. Century Therapeutics Inc. IPSC$2.7 million last quarter

What it holds

CompanySharesValueOf its bookChange in shares
Autolus Therapeutics PLC AUTL16,640,720$26.63 billion100.00%no change
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before; the 1 it sold out of are in the box above.